Globular adiponectin induces a pro-inflammatory response in human astrocytic cells

Area of Science:

• Neuroscience
• Immunology
• Endocrinology

Background:

• Neuroinflammation, involving activated astrocytes, is crucial in neurodegenerative diseases like Alzheimer's disease (AD).
• Adiponectin, an adipokine, has varied effects in peripheral tissues, but its role in astrocytes is unknown.
• Altered adiponectin levels may link midlife obesity to increased AD risk.

Purpose of the Study:

• To investigate the effects of globular adiponectin (gAd) on pro-inflammatory cytokine expression and secretion in human astrocytic cells.
• To explore the involvement of key signaling pathways (NF-κB, MAPK, ERK, JNK, PI3K) in gAd-mediated astrocyte activation.

Main Methods:

• Demonstrated expression of adiponectin receptors (adipoR1, adipoR2) in U373 MG astrocytic cells and primary human astrocytes.
• Administered gAd to cells and measured pro-inflammatory cytokine mRNA and protein levels.
• Utilized specific pathway inhibitors (NF-κB, p38 MAPK, ERK1/2, JNK, PI3K) to dissect signaling mechanisms.

Main Results:

• gAd significantly induced the secretion of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1).
• gAd upregulated the gene expression of IL-6, MCP-1, IL-1β, and IL-8 in astrocytic cells.
• NF-κB, p38 MAPK, and ERK1/2 signaling pathways were implicated in gAd-induced cytokine production, with ERK1/2 showing the most significant contribution.

Conclusions:

• Globular adiponectin (gAd) can promote a pro-inflammatory phenotype in human astrocytes.
• The findings suggest a potential mechanism linking adiponectin dysregulation to neuroinflammation and AD pathogenesis.
• Targeting adiponectin signaling in astrocytes may offer therapeutic strategies for neurodegenerative diseases.